Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
1. October 2024
3 min to read

Evaluating AI Prediction of Occlusive Myocardial Infarction from 12-lead ECGs After Resuscitated Out-of-Hospital Cardiac Arrest

Overview

Rapid detection of coronary vessel blockage in out-of-hospital-cardiac-arrest (OHCA) patients is crucial, as timely treatment improves survival and neurological outcomes. Standard ECG criteria often miss critical markers, delaying treatment. This analysis showed that the PMcardio STEMI AI ECG Model could detect them with high accuracy (88.7% sensitivity, 81.4% specificity), demonstrating its potential to speed up diagnosis and improve patient care.

Published In: Journal of the American College of Cardiology (JACC) – presented at the TCT’24 Annual Conference
Presented Date: October 27, 2024

Background

Identifying occlusive myocardial infarction (OMI) on electrocardiograms (ECGs) after resuscitated out-of-hospital cardiac arrest (OHCA) remains challenging. Even in the absence of ST-elevation, acute lesions may still be present. We evaluated OMI prediction in post-OHCA ECGs by an artificial intelligence (AI) model (PMCardio-Queen of Hearts [Medicines and Healthcare Products Regulatory Agency registered and CE certified]).

Methods

In this retrospective study, the Al model was used to predict OMI on post-return of spontaneous circulation 12 lead ECGs of unselected OHCA patients who underwent coronary angiography at operator discretion in two high-volume cardiac arrest centers. AI predictions were compared to invasive coronary angiographic findings.

OMI was defined as elevated troponin by the fourth universal myocardial infarction definition with an acute culprit coronary stenosis with reduced flow (Thrombolysis In Myocardial Infarction flow grade S 2). We then evaluated the Al model’s performance for identifying angiographically confirmed OMI.

Results

A total of 160 OHCA cases were included, with a mean age of 64.9 +/- 14.92 years; 74% were male, and 80% had shockable rhythms. ST-segment elevation myocardial infarction criteria were present in 38% of cases, and 20% had a bundle branch block. On invasive coronary angiography, OMI was identified in 61% of cases.

The Al model demonstrated a sensitivity of 0.887 (95% Cl: 0.80-0.97), specificity of 0.814 (95% CI: 0.74-0.88), and a positive predictive value of 0.708 (95% CI: 0.612-0.804) with an area under the curve of 0.85.

Conclusion

The AI model demonstrates high sensitivity, specificity, and positive predictive value for OMI. However, since it was not specifically trained on post–return of spontaneous circulation (ROSC) ECGs, further training on OHCA datasets is necessary to enhance its accuracy in detecting ECG changes suggestive of OMI in post-OHCA patients.

This application may serve as a valuable adjunct to clinical assessment in identifying OHCA patients who could benefit from life-saving coronary intervention.

Authors: Uzma Sajjad, Rupert Simpson, Sarosh Khan, Michael McGarvey, Muhamad Abd Razak, Klio Konstantinou, Christopher Cook, Nilesh Pareek, Xue Qiang, Grigoris Karamasis, Thomas Keeble, John Davies

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. Registry

In a large, multi-center evaluation presented as Late-Breaking Science at the TCT 2025 conference, investigators assessed the diagnostic accuracy of the Queen of Hearts™ AI algorithm for ST-segment elevation myocardial infarction (STEMI) detection in emergency care. The study compared AI-enhanced ECG interpretation against standard triage protocols across three U.S. PCI centers, encompassing more than 1,000 patients who activated emergent reperfusion pathways. Published in JACC: Cardiovascular Interventions, the results demonstrated significantly improved accuracy and reduced false activations when using AI-driven analysis.

Electrocardiographic Diagnostic Possibilities for Atrial Fibrillation Using Artificial Intelligence: Differentiation from Sinus Rhythm and Other Arrhythmias with the Pmcardio App in Covid-19 Patients

This study evaluated how effectively artificial intelligence can detect atrial fibrillation (AF) in COVID-19 patients using ECG analysis. Researchers compared the PMcardio AI application’s performance with that of cardiologists and infectious disease specialists. Among 116 hospitalized COVID-19 patients, PMcardio achieved perfect diagnostic accuracy (sensitivity and specificity of 1.00) for AF detection, matching cardiologists and surpassing infectious disease specialists. The AI’s performance remained consistent across confidence levels, and its severity assessments correlated significantly with rhythm findings. These results highlight AI’s potential to improve arrhythmia detection, streamline care, and reduce unnecessary in-person evaluations during infectious disease outbreaks.

Join over 100,000 healthcare professionals who are already taking advantage of AI